Literature DB >> 12047736

Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users.

Julia H Arnsten1, Penelope A Demas, Richard W Grant, Marc N Gourevitch, Homayoon Farzadegan, Andrea A Howard, Ellie E Schoenbaum.   

Abstract

Despite a burgeoning literature on adherence to HIV therapies, few studies have examined the impact of ongoing drug use on adherence and viral suppression, and none of these have utilized electronic monitors to quantify adherence among drug users. We used 262 electronic monitors to measure adherence with all antiretrovirals in 85 HIV-infected current and former drug users, and found that active cocaine use, female gender, not receiving Social Security benefits, not being married, screening positive for depression, and the tendency to use alcohol or drugs to cope with stress were all significantly associated with poor adherence. The strongest predictor of poor adherence and, in turn, failure to maintain viral suppression, was active cocaine use. Overall adherence among active cocaine users was 27%, compared to 68% among subjects who reported no cocaine use during the 6-month study period. Consequently, 13% of active cocaine users maintained viral suppression, compared to 46% of nonusers. Interventions to improve adherence should focus on reducing cocaine use, developing adaptive coping skills, and identifying and treating depression.

Entities:  

Mesh:

Year:  2002        PMID: 12047736      PMCID: PMC1495042     

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  19 in total

1.  Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic.

Authors:  J McNabb; J W Ross; K Abriola; C Turley; C H Nightingale; D P Nicolau
Journal:  Clin Infect Dis       Date:  2001-07-30       Impact factor: 9.079

2.  A comparison study of multiple measures of adherence to HIV protease inhibitors.

Authors:  H Liu; C E Golin; L G Miller; R D Hays; C K Beck; S Sanandaji; J Christian; T Maldonado; D Duran; A H Kaplan; N S Wenger
Journal:  Ann Intern Med       Date:  2001-05-15       Impact factor: 25.391

3.  Severe adverse life events and depressive symptoms among women with, or at risk for, HIV infection in four cities in the United States of America.

Authors:  J Moore; P Schuman; E Schoenbaum; B Boland; L Solomon; D Smith
Journal:  AIDS       Date:  1999-12-03       Impact factor: 4.177

4.  Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

Authors:  D R Bangsberg; F M Hecht; E D Charlebois; A R Zolopa; M Holodniy; L Sheiner; J D Bamberger; M A Chesney; A Moss
Journal:  AIDS       Date:  2000-03-10       Impact factor: 4.177

5.  The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group.

Authors:  R H Haubrich; S J Little; J S Currier; D N Forthal; C A Kemper; G N Beall; D Johnson; M P Dubé; J Y Hwang; J A McCutchan
Journal:  AIDS       Date:  1999-06-18       Impact factor: 4.177

6.  Assessing coping strategies: a theoretically based approach.

Authors:  C S Carver; M F Scheier; J K Weintraub
Journal:  J Pers Soc Psychol       Date:  1989-02

7.  Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection.

Authors:  G M Lucas; L W Cheever; R E Chaisson; R D Moore
Journal:  J Acquir Immune Defic Syndr       Date:  2001-07-01       Impact factor: 3.731

8.  Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy.

Authors:  N Singh; S M Berman; S Swindells; J C Justis; J A Mohr; C Squier; M M Wagener
Journal:  Clin Infect Dis       Date:  1999-10       Impact factor: 9.079

9.  Predictors of nonadherence to HIV-related medication regimens during methadone stabilization.

Authors:  S K Avants; A Margolin; L A Warburton; K A Hawkins; J Shi
Journal:  Am J Addict       Date:  2001

10.  Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users.

Authors:  D D Celentano; N Galai; A K Sethi; N G Shah; S A Strathdee; D Vlahov; J E Gallant
Journal:  AIDS       Date:  2001-09-07       Impact factor: 4.177

View more
  256 in total

1.  Substance abuse: the expanding role of general internal medicine.

Authors:  Patrick G O'Connor; Jeffrey H Samet
Journal:  J Gen Intern Med       Date:  2002-05       Impact factor: 5.128

2.  Alcohol use accelerates HIV disease progression.

Authors:  Marianna K Baum; Carlin Rafie; Shenghan Lai; Sabrina Sales; John Bryan Page; Adriana Campa
Journal:  AIDS Res Hum Retroviruses       Date:  2010-05       Impact factor: 2.205

3.  Antiretroviral adherence during pregnancy and postpartum in Latin America.

Authors:  Regis Kreitchmann; D Robert Harris; Fabiana Kakehasi; Jessica E Haberer; Pedro Cahn; Marcelo Losso; Elizabete Teles; Jose H Pilotto; Cristina B Hofer; Jennifer S Read
Journal:  AIDS Patient Care STDS       Date:  2012-06-04       Impact factor: 5.078

Review 4.  A systematic review of behavioral and treatment outcome studies among HIV-infected men who have sex with men who abuse crystal methamphetamine.

Authors:  Radha Rajasingham; Matthew J Mimiaga; Jaclyn M White; Megan M Pinkston; Rachel P Baden; Jennifer A Mitty
Journal:  AIDS Patient Care STDS       Date:  2011-11-09       Impact factor: 5.078

5.  HIV-infected individuals who use alcohol and other drugs, and virologic suppression.

Authors:  Seonaid Nolan; Alexander Y Walley; Timothy C Heeren; Gregory J Patts; Alicia S Ventura; Meg M Sullivan; Jeffrey H Samet; Richard Saitz
Journal:  AIDS Care       Date:  2017-05-17

6.  The importance of how research participants think they are perceived: results from an electronic monitoring study of antiretroviral therapy in Uganda.

Authors:  Jeffrey I Campbell; Angella Musiimenta; Bridget Burns; Sylvia Natukunda; Nicholas Musinguzi; Jessica E Haberer; Nir Eyal
Journal:  AIDS Care       Date:  2018-12-09

7.  Reliability and validity of the Haitian Creole PHQ-9.

Authors:  Linda G Marc; Whitney R Henderson; Astrid Desrosiers; Marcia A Testa; Samuel E Jean; Eniko Edit Akom
Journal:  J Gen Intern Med       Date:  2014-08-05       Impact factor: 5.128

8.  Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial.

Authors:  Frederick L Altice; Duncan Smith-Rohrberg Maru; R Douglas Bruce; Sandra A Springer; Gerald H Friedland
Journal:  Clin Infect Dis       Date:  2007-08-13       Impact factor: 9.079

9.  Prevalence of HIV Viral Load Suppression Among Psychiatric Inpatients with Comorbid Substance Use Disorders.

Authors:  D M Coviello; R Lovato; K Apostol; M M Eisenberg; D S Metzger; R Szucs-Reed; N Kiryankova-Dalseth; D Kelly; A Jackson; M Plano; M B Blank
Journal:  Community Ment Health J       Date:  2018-05-11

Review 10.  Epigenetics, drugs of abuse, and the retroviral promoter.

Authors:  Jasmine Shirazi; Sonia Shah; Divya Sagar; Michael R Nonnemacher; Brian Wigdahl; Zafar K Khan; Pooja Jain
Journal:  J Neuroimmune Pharmacol       Date:  2013-11-12       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.